Malaisse W J, Devis G, Pipeleers D G, Somers G
Diabetologia. 1976 Mar;12(1):77-81. doi: 10.1007/BF01221969.
D600 (2 to 20 muM; alpha-isopropyl-alpha [(N-methyl-N-homoveratril)-gamma-aminopropyl]-3,4,5-trimethoxyphenyl-acetonitril) caused a dose-related, rapid and reversible inhibition of glucose-induced insulin release. It also suppressed the insulinotropic action of a sulphonylurea but failed to affect the enhancing action of theophylline upon glucose-induced release. The inhibitory effect of D600 was enhanced at low extracellular Ca2+ concentration. D600 reduced both basal and glucose-stimulated 45calcium net uptake, whilst failing to affect the efflux of 45calcium from perifused islets. The recognition of glucose by the B-cell was also unaffected by D600 as judged by the effect of the sugar upon both 45calcium efflux and net uptake in the isolated islets. These findings are compatible with the hypothesis that the primary mode of action of D600 is to inhibit Ca2+ entry in the B-cell.
D600(2至20微摩尔;α-异丙基-α-[(N-甲基-N-高藜芦基)-γ-氨基丙基]-3,4,5-三甲氧基苯基-乙腈)引起与剂量相关的、快速且可逆的对葡萄糖诱导的胰岛素释放的抑制作用。它还抑制了磺酰脲类药物的促胰岛素作用,但未能影响茶碱对葡萄糖诱导释放的增强作用。在低细胞外钙离子浓度时,D600的抑制作用增强。D600降低了基础状态和葡萄糖刺激下的45钙净摄取量,同时未能影响45钙从灌注胰岛的流出。从糖对分离胰岛中45钙流出和净摄取的影响判断,D600对B细胞识别葡萄糖也没有影响。这些发现与D600的主要作用模式是抑制钙离子进入B细胞这一假说相符。